These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36541589)

  • 1. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19.
    Dagher H; Chaftari AM; Mulanovich P; Jiang Y; Hachem R; Malek AE; Borjan J; Viola GM; Raad I
    Elife; 2022 Dec; 11():. PubMed ID: 36541589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
    Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
    J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Discordant Procalcitonin Use at an Academic Medical Center.
    Seymann GB; Bevins N; Wu C; Fitzgerald R
    Am J Clin Pathol; 2022 Jun; 157(6):890-898. PubMed ID: 34894127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
    Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
    Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
    Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
    J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19.
    Wolfisberg S; Gregoriano C; Schuetz P
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):54-65. PubMed ID: 34517744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to best use procalcitonin to diagnose infections and manage antibiotic treatment.
    Schuetz P
    Clin Chem Lab Med; 2023 Apr; 61(5):822-828. PubMed ID: 36317790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
    Cowman K; Rossi J; Gendlina I; Guo Y; Liu S; Szymczak W; Forest SK; Wolgast L; Orner E; Bao H; Cervera-Hernandez ME; Ceniceros A; Thota R; Pirofski LA; Nori P
    Diagn Microbiol Infect Dis; 2022 Aug; 103(4):115721. PubMed ID: 35635888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
    Lee CC; Kwa ALH; Apisarnthanarak A; Feng JY; Gluck EH; Ito A; Karuniawati A; Periyasamy P; Pratumvinit B; Sharma J; Solante R; Swaminathan S; Tyagi N; Vu DM; Zirpe K; Schuetz P
    Clin Chem Lab Med; 2020 Nov; 58(12):1983-1991. PubMed ID: 31926074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin Testing With Secondary Coinfection in Patients With COVID-19.
    Nadeem R; Aljaghber HM; Elgohary D; Rafeeq A; Aijazi I; Khan HA; Khan MR; Velappan B; Aljanahi MH; Mohamed Ali Elzeiny MG
    Cureus; 2022 Sep; 14(9):e28898. PubMed ID: 36237753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit.
    Wang X; Long Y; Su L; Zhang Q; Shan G; He H
    Front Cell Infect Microbiol; 2022; 12():844134. PubMed ID: 35360102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.